IACP Rolls out Advocacy Effort - Let Your Senators Know S. 959 Must be Fixed!
The International Academy of Compounding Pharmacists (IACP) has worked diligently and cooperatively for more than 9 months with the members and staff of the U.S. Senate’s Committee on Health, Education, Labor and Pensions (HELP) as it works to produce an effective legislative solution to address the failures of state and federal regulators to prevent the illegal activities of the New England Compounding Center (NECC). These failures led to a meningitis outbreak that led to 61 deaths and hundreds of illnesses across the country. Unfortunately, the voices of pharmacists, practitioner groups and patient groups have yet to be incorporated into this legislation.
IACP urges all of its members to review the legislation and to contact your respective U.S. Senators to voice your grave concerns about specific provisions in the bill that could negatively impact the practice of pharmacy compounding and hinder patient and practitioner access to vital compounded medications.
As written, S. 959 is too far-reaching in its scope and micromanagement of practitioner decisions. Major sections of S. 959 must fixed because the bill is just unworkable for pharmacists and physicians. Of particular concern is the broad “gimmees” that were provided to the pharmaceutical industry to protect their profits and new powers that give the FDA oversight of traditional compounding and assure the ability of physicians to make informed decisions about appropriate medication therapy. IACP believes that S. 959 rewards the FDA without holding the agency accountable for its past inaction and failure to protect the public.
We need you to contact your Senators as soon as possible to voice your concerns about S. 959 since it is scheduled to come to the Senate Floor next week. In advance, we thank you for your help on these critical issues!
IACP Members: Click here to participate in this important advocacy effort!